List of works - Carlota Recio

Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses In Vivo.

scientific article published on 21 November 2017

Activation of the Immune-Metabolic Receptor GPR84 Enhances Inflammation and Phagocytosis in Macrophages.

scientific article

Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo

scientific article published on 30 August 2016

Cannabinoid Receptor 2 Modulates Neutrophil Recruitment in a Murine Model of Endotoxemia.

scientific article published on 09 August 2017

Fcγ receptor deficiency attenuates diabetic nephropathy

scientific article published on 2 August 2012

Gene Deficiency in Activating Fcγ Receptors Influences the Macrophage Phenotypic Balance and Reduces Atherosclerosis in Mice.

scientific article

Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice

scientific article published on 21 January 2015

In Vitro Migration Assays

scientific article published on 01 January 2018

Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosis.

scientific article published on 7 February 2017

Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms

scientific article published on 31 July 2018

Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis

scientific article published on 16 April 2013

Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.

scientific article

SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition

scientific article published on 14 March 2018

Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology

scientific article published on 19 February 2019

Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.

scientific article

Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.

scientific article

Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice

scientific article published on 26 June 2015

The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease

scientific article published on January 2016

The Role of Metabolite-sensing G Protein-Coupled Receptors in inflammation and metabolic disease.

scientific article published on 8 November 2017

List of works by Carlota Recio

Absence of the Non-Signalling Chemerin Receptor CCRL2 Exacerbates Acute Inflammatory Responses In Vivo.

Activation of the Immune-Metabolic Receptor GPR84 Enhances Inflammation and Phagocytosis in Macrophages.

Acute exposure to apolipoprotein A1 inhibits macrophage chemotaxis in vitro and monocyte recruitment in vivo

Cannabinoid Receptor 2 Modulates Neutrophil Recruitment in a Murine Model of Endotoxemia.

Fcγ receptor deficiency attenuates diabetic nephropathy

Gene Deficiency in Activating Fcγ Receptors Influences the Macrophage Phenotypic Balance and Reduces Atherosclerosis in Mice.

Gene delivery of suppressors of cytokine signaling (SOCS) inhibits inflammation and atherosclerosis development in mice

In Vitro Migration Assays

Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosis.

Nrf2 Activation Provides Atheroprotection in Diabetic Mice Through Concerted Upregulation of Antioxidant, Anti-inflammatory, and Autophagy Mechanisms

Peptide inhibitor of NF-κB translocation ameliorates experimental atherosclerosis

Peptide-based inhibition of IκB kinase/nuclear factor-κB pathway protects against diabetes-associated nephropathy and atherosclerosis in a mouse model of type 1 diabetes.

SOCS1-targeted therapy ameliorates renal and vascular oxidative stress in diabetes via STAT1 and PI3K inhibition

Signal transducer and activator of transcription (STAT)-5: an opportunity for drug development in oncohematology

Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.

Suppressor of cytokine signaling 1-derived peptide inhibits Janus kinase/signal transducers and activators of transcription pathway and improves inflammation and atherosclerosis in diabetic mice.

Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice

The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease

The Role of Metabolite-sensing G Protein-Coupled Receptors in inflammation and metabolic disease.